

MBChB (New Zealand), PGDipObstMedGyn, FRACP (New Zealand), FAMS (Rheumatology)
Joint pain and stiffness can be easy to put down to ageing, overuse or simply “arthritis”. But when symptoms keep returning, affect several joints or make everyday movement more difficult, you may start to wonder what is actually causing them.
Two common possibilities are rheumatoid arthritis and osteoarthritis. Although they can cause similar symptoms, they develop for different reasons and may affect the joints in different patterns. Knowing which one is causing your symptoms matters because the approach to diagnosis and treatment differs, particularly when rheumatoid arthritis requires timely treatment to help prevent joint damage.
While both conditions affect the joints, the pattern of symptoms and how they develop can offer useful clues as to which may be responsible.
| Comparison point | Rheumatoid Arthritis | Osteoarthritis |
|---|---|---|
| What it is | An autoimmune inflammatory disease | A condition involving changes to cartilage and other structures within the joint |
| Commonly affected joints | Hands, wrists and feet | Knees, hips, hands and spine |
| Joint pattern | Often affects the same joints on both sides of the body | May affect joints unevenly |
| Morning stiffness | Often prolonged after waking or resting | Usually shorter-lived and eases with movement |
| Effect of activity | Stiffness may improve with gentle movement | Pain may become more noticeable with joint use |
| Beyond the joints | May cause fatigue and other symptoms elsewhere in the body | Symptoms are generally limited to the affected joints |
| Treatment focus | Control inflammation and disease activity | Reduce symptoms and maintain joint function |
Although both conditions can result in painful and stiff joints, the processes behind them are very different.
Rheumatoid arthritis develops when the immune system mistakenly attacks the lining of the joints, causing ongoing inflammation. Over time, uncontrolled inflammation can damage cartilage, bone and other structures within the joint.
The exact reason this autoimmune response develops is not fully understood. Genetics can influence susceptibility, while factors such as smoking may increase the risk in some people.
Osteoarthritis develops as cartilage and other tissues within a joint gradually change and become damaged. This can reduce the joint’s ability to move smoothly and may eventually lead to changes in the underlying bone.
Although osteoarthritis is sometimes described simply as “wear and tear”, ageing is not the only factor involved. Previous joint injuries, repeated mechanical stress and the way a joint is structured can also contribute to its development.
Joint pain and stiffness can occur with both conditions. The differences often become clearer when you look at when symptoms occur, which joints are involved and how the body is affected overall.
No single symptom can reliably distinguish one condition from the other, so the overall pattern and clinical assessment are important when determining the cause of persistent joint symptoms.
Diagnosis usually begins with the pattern of symptoms and a physical examination of the affected joints. Blood tests and imaging may then be used to help distinguish between the two conditions.
If rheumatoid arthritis is suspected, assessment may include:
Blood tests can support a diagnosis, but they do not provide the answer on their own. Some people with rheumatoid arthritis do not have these antibodies, so normal antibody results do not necessarily rule out the condition.
Osteoarthritis is often diagnosed based on symptoms and examination of the affected joint. A doctor may assess movement, tenderness, swelling and how the joint functions.
X-rays may be used when needed to look for changes associated with osteoarthritis, such as narrowing of the joint space or changes in the bone. However, imaging findings do not always match how severe a person’s symptoms feel, so the diagnosis is considered alongside the clinical picture.
Treatment differs because the two conditions affect the joints in different ways. Rheumatoid arthritis treatment aims to control the underlying autoimmune inflammation, while osteoarthritis treatment focuses on relieving symptoms and maintaining joint function.
Early treatment is important because ongoing inflammation can progressively damage the joints. Disease-modifying anti-rheumatic drugs (DMARDs) form the mainstay of rheumatoid arthritis treatment because they target disease activity rather than simply relieving pain.
Depending on the individual and how active the condition is, treatment may include:
Treatment is monitored over time and may be adjusted according to symptoms, blood tests and disease activity.
Unlike rheumatoid arthritis, osteoarthritis treatment does not involve DMARDs to control an autoimmune disease process. Instead, management aims to reduce pain, maintain mobility and support the function of the affected joint.
Depending on the joint and severity of symptoms, this may involve exercise or physiotherapy, pain-relieving medication, weight management where relevant, or joint injections in selected cases. Surgery may be considered when osteoarthritis is advanced and symptoms continue to significantly affect daily function despite other treatment.

Occasional joint aches do not necessarily indicate rheumatoid arthritis. However, certain patterns of persistent joint symptoms may warrant further assessment, particularly when inflammation is suspected.
Consider seeing a rheumatologist if you experience:
Early assessment is particularly important when rheumatoid arthritis is suspected, as timely treatment can help control inflammation before irreversible joint damage develops.
Persistent joint pain or stiffness can have different causes, and an accurate diagnosis helps determine the appropriate treatment approach. This is particularly important when an inflammatory condition such as rheumatoid arthritis is suspected, as controlling the disease early can help limit ongoing inflammation and reduce the risk of joint damage.
At Centre for Rheumatology & Arthritis, patients with persistent or inflammatory joint symptoms can receive assessment to determine the underlying cause and discuss appropriate treatment options. Dr Poh Yih Jia provides care for rheumatoid arthritis and other forms of inflammatory arthritis, with treatment focused on controlling disease activity and preserving joint function.
Schedule a consultation if you have persistent joint pain, swelling or stiffness and would like to have your symptoms assessed.
Yes. Rheumatoid arthritis and osteoarthritis are different conditions, but having one does not prevent you from developing the other. For example, someone receiving treatment for rheumatoid arthritis may also develop osteoarthritis in certain joints. Identifying which condition is responsible for particular symptoms can help guide treatment.
No. Osteoarthritis does not develop into rheumatoid arthritis. They arise through different disease processes, so one does not transform into the other. However, a person with osteoarthritis can separately develop rheumatoid arthritis, which is why new patterns of swelling, prolonged stiffness or inflammation may need further assessment.
Rheumatoid arthritis is not directly inherited, but genetics can influence a person’s susceptibility to developing it. Having a family member with rheumatoid arthritis may increase your risk, but it does not mean you will necessarily develop the condition. Other factors are also involved in triggering the autoimmune response.
Dr Poh Yih Jia is a senior consultant rheumatologist with a special interest in lupus, arthritis and the
management of autoimmune diseases during pregnancy. Before entering private practice, she spent over a
decade at Singapore General Hospital, where she established the Rheumatology Obstetrics Clinic and
spearheaded the development of its multidisciplinary Gout Clinic.
Her work extends beyond clinical practice to improving how rheumatological conditions are managed. Dr
Poh has contributed to regional lupus collaborations and served on the expert panel for the Ministry of
Health Agency for Care Effectiveness (ACE) Clinical Guidance on Gout. She has also been actively
involved in rheumatology research, medical education and the training of future specialists.
